PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
4.59%
Revenue growth at 50-75% of CVE's 8.52%. Martin Whitman would worry about competitiveness or product relevance.
7.03%
Gross profit growth under 50% of CVE's 16.15%. Michael Burry would be concerned about a severe competitive disadvantage.
-152.91%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-152.91%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-305.00%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-306.17%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-306.17%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
No Data
No Data available this quarter, please select a different quarter.
-0.18%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
-16.98%
Negative OCF growth while CVE is at 3.37%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-21.43%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
94.91%
10Y revenue/share CAGR at 75-90% of CVE's 123.31%. Bill Ackman would press for new markets or product lines to narrow the gap.
-24.34%
Negative 5Y CAGR while CVE stands at 123.31%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-62.20%
Negative 3Y CAGR while CVE stands at 123.31%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
198.22%
10Y OCF/share CAGR above 1.5x CVE's 22.86%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
-19.41%
Negative 5Y OCF/share CAGR while CVE is at 22.86%. Joel Greenblatt would question the firm’s operational model or cost structure.
-44.64%
Negative 3Y OCF/share CAGR while CVE stands at 22.86%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-444.10%
Negative 10Y net income/share CAGR while CVE is at 371.76%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-145.86%
Negative 5Y net income/share CAGR while CVE is 371.76%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-123.28%
Negative 3Y CAGR while CVE is 371.76%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
347.81%
Positive growth while CVE is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.
14.67%
Positive 5Y equity/share CAGR while CVE is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
-27.59%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
956.80%
Stable or rising dividend while CVE is cutting. John Neff sees a strong advantage in consistent shareholder returns vs. a struggling peer.
131.87%
Stable or rising mid-term dividends while CVE is cutting. John Neff sees an edge in consistent payouts vs. the competitor.
-50.07%
Both firms reduced dividends recently. Martin Whitman suspects broader macro or industry issues forcing cost and payout cuts.
2.03%
AR growth is negative/stable vs. CVE's 8.06%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
100.00%
Inventory growth well above CVE's 6.43%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-2.16%
Negative asset growth while CVE invests at 3.90%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-1.54%
We have a declining book value while CVE shows 1.08%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-6.57%
We’re deleveraging while CVE stands at 48.74%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
137.21%
SG&A growth well above CVE's 134.21%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.